In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi‐dimensional classification

Several multi‐dimensional statistical evaluation methods were applied to single‐voxel proton MR spectra of glial brain tumors and of healthy volunteers. Metabolic coordinates with histological relevance for future diagnosis were found by which spectra from controls, low‐grade tumors, and highgrade tumors were completely separated. Significant differences between low‐grade and high‐grade glioma patients and controls were found for several metabolic ratios by variance analysis. Cluster analysis both with and without principal component analysis was applied. The outcome of these two approaches depended mainly on the lipid‐to‐creatine ratio. Two other approaches, discriminant factor analysis and the orthonormal discriminant vector method were then used to find discriminatory metabolic coordinates. It turned out that a linear combination of all evaluable metabolic ratios made it possible to separate the three groups completely. On the basis of these results, a classification method that uses the entire proton MRS spectrum is proposed.

[1]  Allen H. Reed,et al.  The Statistical Analysis of Data , 1986 .

[2]  J R Griffiths,et al.  Classification of tumour 1H NMR spectra by pattern recognition , 1992, NMR in biomedicine.

[3]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[4]  J. Pettegrew,et al.  N‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brain , 1992, Neurology.

[5]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[6]  U. Klose In vivo proton spectroscopy in presence of eddy currents , 1990, Magnetic resonance in medicine.

[7]  J. Valk,et al.  1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders , 1992, Annals of neurology.

[8]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[9]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[10]  J. Voges,et al.  In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.

[11]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[12]  J R Griffiths,et al.  An Investigation of Tumor 1H Nuclear Magnetic Resonance Spectra by the Application of Chemometric Techniques , 1992, Magnetic resonance in medicine.

[13]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[14]  D. Gusnard,et al.  Proton magnetic resonance spectroscopy of pediatric brain tumors. , 1992, Neurosurgery.

[15]  J. Vion-Dury,et al.  A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases , 1993, Journal of Neurological Sciences.

[16]  P R Luyten,et al.  Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging , 1990, Magnetic resonance in medicine.

[17]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[18]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[19]  Yoshihiko Hamamoto,et al.  On a theoretical comparison between the orthonormal discriminant vector method and discriminant analysis , 1993, Pattern Recognit..

[20]  J A Frank,et al.  Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.

[21]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[22]  Takashi Ogino,et al.  Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain , 1993, Magnetic resonance in medicine.

[23]  Peter J. Rousseeuw,et al.  Finding Groups in Data: An Introduction to Cluster Analysis , 1990 .

[24]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[25]  J. Frahm,et al.  On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro , 1992, NMR in biomedicine.

[26]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[27]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[28]  Y. Yoshioka,et al.  In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis , 1993, Magnetic resonance in medicine.

[29]  O Henriksen,et al.  Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites , 1994, NMR in biomedicine.

[30]  C T Moonen,et al.  Short echo time proton MR spectroscopic imaging. , 1993, Journal of computer assisted tomography.

[31]  J. Frahm,et al.  Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.

[32]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[33]  G. Barker,et al.  Detection of myelin breakdown products by proton magnetic resonance spectroscopy , 1993, The Lancet.